Provided by Tiger Trade Technology Pte. Ltd.

Henry Schein

88.50
+0.04000.05%
Volume:758.82K
Turnover:67.18M
Market Cap:9.82B
PE:25.79
High:89.11
Open:88.74
Low:88.19
Close:88.46
52wk High:92.18
52wk Low:61.95
Shares:111.00M
Float Shares:94.38M
Volume Ratio:0.69
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.43
EPS(LYR):3.27
ROE:8.85%
ROA:4.39%
PB:3.11
PE(LYR):27.06

Loading ...

Henry Schein Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 11

How Investors May Respond To Henry Schein (HSIC) Earnings, Buybacks And New AI-Enabled Dentrix Ascend Packages

Simply Wall St.
·
Mar 10

Henry Schein Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 07

Henry Schein Director Philip A. Laskawy Disposes of Common Shares

Reuters
·
Mar 07

Henry Schein Conference Appearances Spotlight Valuation Upside And Debt Risk

Simply Wall St.
·
Mar 05

Henry Schein Chairman Stanley M. Bergman Reports Disposal of Common Shares

Reuters
·
Mar 03

Henry Schein to Present at Leerink and Barclays Global Healthcare Conferences

Reuters
·
Mar 03

Henry Schein Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 03

Henry Schein Inc. Files Initial Beneficial Ownership Statement for CEO and Director Frederick M. Lowery

Reuters
·
Mar 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC), Dyadic International (DYAI) and Bioventus (BVS)

TIPRANKS
·
Mar 02

Jefferies Adjusts Price Target on Henry Schein to $89 From $72, Maintains Hold Rating

MT Newswires Live
·
Mar 02

Will Strong Q4 2025 Results and Impairment Charge Reframe Henry Schein's (HSIC) Investment Narrative?

Simply Wall St.
·
Mar 02

Henry Schein Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

Henry Schein Chairman and CEO Stanley M. Bergman Disposes of Common Shares

Reuters
·
Feb 28

Henry Schein Inc. Releases Transcript of Fourth Quarter 2025 Earnings Call

Reuters
·
Feb 27

Biomerica Reports Real-World Data: Nearly 60% of Ibs Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction With the Infoods® Ibs Therapy

THOMSON REUTERS
·
Feb 26

Henry Schein Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 26

These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results

Benzinga_recent_news
·
Feb 26

Henry Schein Is Maintained at Underweight by Morgan Stanley

Dow Jones
·
Feb 25

Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC)

TIPRANKS
·
Feb 25